MERLIN Biotech CEO Randall N. Hyer delivers details – and a comprehensive strategic plan – for the company’s promising mRNA technology MERLIN Biotech, a spinout from the Baruch S. Blumberg Institute, presented its first asset last month

By Damon Williams, Bucks County Courier Times Photo by Nur B. Adam, Bucks County Courier Times Timely state investment and cutting-edge laboratories and support has positioned the Doylestown-based Pennsylvania Biotechnology Center as crucial cog in Bucks County's